Top Authors

• Most frequent coverage on LGND

• 
  Mike Havrilla (1934 followers)

  • Stocks Affected by FDA Calendar of Expected Decision Dates (Wed, Jan 14)
  • 73 Decision Dates on Updated FDA Calendar (Sat, Nov 22)
  • Backlog of Decisions Is Building at the FDA (Sat, Nov 8)

  More by Mike Havrilla on LGND »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on LGND »
• 
  The Burrill Report (205 followers)

  • This Week in Biotech: More Treats than Tricks (Sun, Nov 1)
  • Several Promising Deals for Biotech (Sun, Aug 30)

  More by The Burrill Report on LGND »

• Most followed authors on LGND

• 
  Mike Havrilla (1934 followers)

  • Stocks Affected by FDA Calendar of Expected Decision Dates (Wed, Jan 14)
  • 73 Decision Dates on Updated FDA Calendar (Sat, Nov 22)
  • Backlog of Decisions Is Building at the FDA (Sat, Nov 8)

  More by Mike Havrilla on LGND »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on LGND »
• 
  Mebane Faber (587 followers)

  • 20 Stocks Owned By Top Activist Funds (Thu, Dec 21)

  More by Mebane Faber on LGND »

• Newest authors on LGND

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on LGND »
• 
  The Burrill Report (205 followers)

  • This Week in Biotech: More Treats than Tricks (Sun, Nov 1)
  • Several Promising Deals for Biotech (Sun, Aug 30)

  More by The Burrill Report on LGND »
• 
  Dividend Inc (210 followers)

  • PCAOB: Our Protectors, Encouraging Malfeasance (Wed, Jul 15)

  More by Dividend Inc on LGND »

• Most commented on LGND

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on LGND »
• 
  Michael Steinberg (163 followers)

  • Three Core Biotech Holdings: Isis, Ligand and Vical (Mon, Nov 9)
  • FDA Stings Pharma, Big and Small (Sun, Jun 22)

  More by Michael Steinberg on LGND »
• 
  Mike Havrilla (1934 followers)

  • Stocks Affected by FDA Calendar of Expected Decision Dates (Wed, Jan 14)
  • 73 Decision Dates on Updated FDA Calendar (Sat, Nov 22)
  • Backlog of Decisions Is Building at the FDA (Sat, Nov 8)

  More by Mike Havrilla on LGND »